Science News
from research organizations

Age-related macular degeneration: Key mechanism in geographic atrophy identified, two possible therapies

Date:
February 7, 2011
Source:
University of Kentucky
Summary:
Scientists have discovered a deficiency of the Dicer enzyme in retinal cells of patients with geographic atrophy. Further research showed that, in the absence of Dicer, toxic Alu RNA can accumulate, leading to retinal cell death characteristic of geographic atrophy. Two therapeutic modalities targeting these mechanisms have been developed and are headed toward clinical trials.
Share:
       
FULL STORY

Geographic atrophy is induced by DICER1 reduction as seen in the retinal photograph (top right, blue arrowheads). This is prevented by blocking Alu RNA (top left). Flat mount pictures show that the degeneration of the RPE cells induced by DICER1 reduction (bottom right) is prevented by blocking Alu RNA (bottom left).
Credit: Ambati Laboratory/University of Kentucky

A team of researchers, led by University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, has discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness in the industrialized world.

Their article was published online by the journal Nature on Feb. 6.

Concurrent with this discovery, Ambati's laboratory developed two promising therapies for the prevention of the condition. This study also elaborates, for the first time, a disease-causing role for a large section of the human genome once regarded as non-coding "junk DNA."

Geographic atrophy, a condition causing the death of cells in the retina, occurs in the later stages of the "dry type" of macular degeneration, a disease affecting some 10 million older Americans and causing blindness in over 1 million. There is currently no effective treatment for geographic atrophy, as its cause is unknown.

Ambati's team discovered that an accumulation of a toxic type of RNA, called Alu RNA, causes retinal cells to die in patients with geographic atrophy. In a healthy eye, a "Dicer" enzyme degrades the Alu RNA particles.

"We discovered that in patients with geographic atrophy, there is a dramatic reduction of the Dicer enzyme in the retina," said Ambati, professor and vice chair of the Department of Ophthalmology and Visual Sciences and the Dr. E. Vernon and Eloise C. Smith Endowed Chair in Macular Degeneration Research at the UK College of Medicine. "When the levels of Dicer decline, the control system is short-circuited and too much Alu RNA accumulates. This leads to death of the retina."

Alu elements make up a surprisingly large portion -- about 11 percent by weight -- of the human genome, comprising more than 1 million sequences. However, their function has been unknown, so they have been called "junk" DNA or part of the "dark" genome. The discovery of Alu's toxicity and its control by Dicer should prove of great interest to other researchers in the biological sciences, Ambati says.

Ambati's team developed two potential therapies aimed at preventing geographic atrophy and demonstrated the efficacy of both approaches using laboratory models. The first involves increasing Dicer levels in the retina by "over-expressing" the enzyme. The second involves blocking Alu RNA using an "anti-sense" drug that binds and degrades this toxic substance. UK has filed patent applications for both technologies, and Ambati's group is preparing to start clinical trials by the end of this year.

"These findings provide important new clues on the biological basis of geographic atrophy and may provide avenues for intervention through preventing toxic accumulation of abnormal RNA products," said Dr. Paul Sieving, director of the National Eye Institute.

"Ambati's latest research provides important mechanistic insights in geographic atrophy, and identification of this novel pathway may result in new therapeutic targets for a major cause of blindness," said Dr. Napoleone Ferrara, a member of the National Academy of Sciences and Lasker-DeBakey awardee who is a researcher at Genentech.

This work has "widespread implications" for future study, said Dr. Stephen J. Ryan, president of the Doheny Eye Institute and member of the Institute of Medicine.

"The authors have opened an important line of research with real possibilities for future therapeutic intervention for patients with geographic atrophy," Ryan said.

Ambati's laboratory is supported by the National Eye Institute and Research to Prevent Blindness. Dr. Ambati is a Doris Duke Charitable Foundation Distinguished Clinical Scientist and Burroughs Wellcome Fund Translational Research Clinical Scientist.


Story Source:

The above post is reprinted from materials provided by University of Kentucky. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hiroki Kaneko, Sami Dridi, Valeria Tarallo, Bradley D. Gelfand, Benjamin J. Fowler, Won Gil Cho, Mark E. Kleinman, Steven L. Ponicsan, William W. Hauswirth, Vince A. Chiodo, Katalin Karikó, Jae Wook Yoo, Dong-ki Lee, Majda Hadziahmetovic, Ying Song, Smita Misra, Gautam Chaudhuri, Frank W. Buaas, Robert E. Braun, David R. Hinton, Qing Zhang, Hans E. Grossniklaus, Jan M. Provis, Michele C. Madigan, Ann H. Milam, Nikki L. Justice, Romulo J. C. Albuquerque, Alexander D. Blandford, Sasha Bogdanovich, Yoshio Hirano, Jassir Witta, Elaine Fuchs, Dan R. Littman, Balamurali K. Ambati, Charles M. Rudin, Mark M. W. Chong, Patrick Provost, Jennifer F. Kugel, James A. Goodrich, Joshua L. Dunaief, Judit Z. Baffi, Jayakrishna Ambati. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature, 2011; DOI: 10.1038/nature09830

Cite This Page:

University of Kentucky. "Age-related macular degeneration: Key mechanism in geographic atrophy identified, two possible therapies." ScienceDaily. ScienceDaily, 7 February 2011. <www.sciencedaily.com/releases/2011/02/110206132904.htm>.
University of Kentucky. (2011, February 7). Age-related macular degeneration: Key mechanism in geographic atrophy identified, two possible therapies. ScienceDaily. Retrieved August 31, 2015 from www.sciencedaily.com/releases/2011/02/110206132904.htm
University of Kentucky. "Age-related macular degeneration: Key mechanism in geographic atrophy identified, two possible therapies." ScienceDaily. www.sciencedaily.com/releases/2011/02/110206132904.htm (accessed August 31, 2015).

Share This Page: